CARDIAC PORTFOLIO

JB Pharma to buy Glenmark cardiac brand for ₹314 crore

With this acquisition, JB Pharma will complete its cardiac portfolio, making it a leader in this segment as Razel ranks among the top 10 brands in the Rosuvastatin molecule category in the country. These brands are focused on the cardiac segment in India and Nepal with a total covered market size of Rs 2,444 crore.